Converge Bio is a startup based in Germany, most recent round Seed, 2 tracked investors.
Converge Bio is a company founded in 2024 headquartered in Germany. Its most recent tracked round is Seed. Brouky records 2 investors associated with the company.
Converge Bio is a biotechnology company developing novel therapeutics for patients suffering from autoimmune diseases. They focus on targeting specific immune cells to create highly effective and safe treatments.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.